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Abstract
The cancer stem cell (CSC) concept is a highly debated topic in cancer research. While experimental evidence in favor of the
cancer stem cell theory is apparently abundant, the results are often criticized as being difficult to interpret. An important
reason for this is that most experimental data that support this model rely on transplantation studies. In this study we use a
novel cellular Potts model to elucidate the dynamics of established malignancies that are driven by a small subset of CSCs.
Our results demonstrate that epigenetic mutations that occur during mitosis display highly altered dynamics in CSC-driven
malignancies compared to a classical, non-hierarchical model of growth. In particular, the heterogeneity observed in CSC-
driven tumors is considerably higher. We speculate that this feature could be used in combination with epigenetic
(methylation) sequencing studies of human malignancies to prove or refute the CSC hypothesis in established tumors
without the need for transplantation. Moreover our tumor growth simulations indicate that CSC-driven tumors display
evolutionary features that can be considered beneficial during tumor progression. Besides an increased heterogeneity they
also exhibit properties that allow the escape of clones from local fitness peaks. This leads to more aggressive phenotypes in
the long run and makes the neoplasm more adaptable to stringent selective forces such as cancer treatment. Indeed when
therapy is applied the clone landscape of the regrown tumor is more aggressive with respect to the primary tumor, whereas
the classical model demonstrated similar patterns before and after therapy. Understanding these often counter-intuitive
fundamental properties of (non-)hierarchically organized malignancies is a crucial step in validating the CSC concept as well
as providing insight into the therapeutical consequences of this model.
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Introduction
Tumor formation and progression are highly dynamic processes
that are driven by the accumulation of genetic lesions that facilitate
the ability of cancer cells to invade surrounding tissue, form
metastases and develop resistance to therapy. As suggested by
Nowell [1], cancer progression is driven by selective pressure on
the cancer cell population as a result of the competition for space
and resources among different malignant cells as well as normal
cells. Recent observations complicate this attractive model by
suggesting that besides clonal (genetic) variations between cancer
cells, the differentiation grade of cells also contributes to the
heterogeneity found in tumors of various kinds [2,3].
Experiments demonstrating that only a small fraction of cancer
cells are capable of transplanting the disease in immuno-
compromised mice led to the speculation that tumors are
hierarchically organized tissues that depend on so-called cancer
stem cells (CSCs) for their long-term growth. This assumption is
supported by the finding that tumor initiating cell populations can
be isolated based on expression of markers that are often associated
with immature cell types in a variety of tissues. For example only the
CD133+ fraction of glioblastoma cells, which make up approxi-
mately 1% of the total tumor cell load, is capable of initiating growth
of a new glioblastoma upon transplantation. Injection of as many as
100,000 CD133+ cells does not result in effective tumor formation
[4]. To date, the evidence for the CSC model of malignancies is
entirely based on transplantation assays [5,6].
Problems with interpretation of the transplantation data include
potential xenotransplantation bias (injection of human cells into
mice), remaining immunological effects in the recipient mice, and
the fact that for isolation of the various cell populations all the
tumor tissue is disrupted. Moreover the fact that the main tumor
mass is not capable of initiating a new tumor does not necessarily
imply that these cells are also incapable of participating in the
growth of an established malignancy. Indeed it is found that
various mouse models of hematological malignancies do not
display a rare CSC compartment when the cells are injected in
autologous mice [7]. Moreover it appears that the type of
immuno-compromised mouse strain used for the transplantation
assay greatly influences the fraction of cells capable of inducing
tumor growth [8]. This has led numerous researchers to warn
against overly optimistic interpretations of these data, and has
resulted in intense debate in the oncology field over the validity of
the CSC concept [5,9,10,11].
Previously, we and others have demonstrated how the analysis
of methylation patterns in regions of the genome rich in CpG
PLoS Computational Biology | www.ploscompbiol.org 1 May 2011 | Volume 7 | Issue 5 | e1001132
dinucleotides (a molecular pattern that can be methylated),
collected from different parts of a tumor, can be a valuable tool
in deciphering the phylogenetic history of malignancies [12,13,14].
The advantage of methylation is the higher mutation rate of
,261025 per site per division [15] compared to DNA point
mutations, such as microsatellites (,10210 [16]). This makes
methylation changes occurring in neutral CpG-rich genomic
regions a powerful and more precise molecular clock that acts as a
cell division counter and allows for the inference of cell phylogeny
within established malignancies. The neutrality of these mutations,
i.e. the fact that these loci are replicated but not transcribed and
expressed, is important because selective forces may disrupt the
relationship between the number of errors and of cell divisions.
Being suitable markers to trace cell fate in tumors, in this study we
model the occurrence of neutral methylation mutations in respect
of pattern heterogeneity and distribution with the aim of
comparing the dynamics of a CSC-driven malignancy to a purely
stochastic, non-hierarchical model of tumor growth that we refer
to as the classical model.
In addition to concerns related to the experimental procedures
that support the CSC theory there are also important theoretical
arguments that challenge the CSC concept. Classical organized
clones, in which all cells are clonogenic, are predicted quickly to
outgrow the hierarchical clones due to favorable growth kinetics.
Therefore, one would expect that evolutionary forces rapidly select
for non-hierarchical cancer cell populations that outcompete the
stem cell driven clones that have retained this organization from
the tissue in which they arose. However, potentially CSC-driven
tumor cell clones display non-intuitive features that are useful in
the process of tumor formation and perhaps even in therapy
resistance. To investigate the different evolutionary dynamics of
the two models and to explore the potential evolutionary benefits
of a hierarchical organization of cancer cells, we expand the
computational model and introduce non-neutral mutations that
can confer a different fitness on cells. In this setting we analyze the
behavior of the different models under different fitness conditions
and landscapes. To conclude, we also study the effect of therapy
on CSC-driven tumors.
Results
We developed a model of tumor growth based on a cellular
Potts approach that can simulate cancer cell proliferation in a
realistic fashion. Our model incorporates the fundamental
processes occurring in cancer growth, such as cell division and
apoptosis. Cellular Potts models have the important benefit of
being able to simulate complex cellular mechanisms such as cell
division, apoptosis and cellular rearrangements realistically and
very efficiently, without the need of artificial assumptions on
cellular mechanics. On top of this we model the occurrence of
neutral methylation mutations and the existence of a hierarchical
organization in the malignant clone, composed of cancer stem cells
(CSC), transient amplifying cells (TAC) and terminally differen-
tiated cells (DC) (see Materials and Methods).
To study the dynamics of neutral epigenetic mutations as markers
of cell populations in cancer [17] we model neutral methylation
changes by assuming that at each cell division errors in copying a
64-CpG dinucleotide region can occur in both the mother and the
daughter cell. We assume methylation and demethylation rates of
m=261025 errors per CpG site per cell division occurring in all
cells, regardless of their proliferative potential or their stemness [15].
To simulate hierarchical tumor organization we assume that CSCs
in the system are able to self-renew with probability y or to divide
asymmetrically with probability 1-y. In the first case the result of the
cell division are two CSCs, in the second the original CSC and a
TAC, able to divide onlyG times before becoming quiescent. Due to
the absence of homeostasis in the tumor we assume that
symmetrical division yielding two transient amplifying cells (CSC
differentiation) does not occur. With this scheme classical clonal
tumor growth in which all cells are tumorigenic is simulated by
setting y=1 (see Materials and Methods for details). The model
parameters are summarized in Table 1.
Neutral epigenetic mutations
We used our cellular Potts model to investigate levels and
distribution patterns of epigenetically distinct clones in both CSC-
driven malignancies as well as in non-hierarchical organized
tumors. Figure 1A and Video S1 display the simulated growth of a
classical malignancy with y=1 whereas Figure 1B and Video S2
shows a CSC malignancy with y=0.1. The total tumor volume in
both experiments is 100,000 cells. While the classical model
exhibits a spherical morphology, a CSC-driven neoplasm is
characterized by irregular tumor borders and invasive patterns
driven by expansion of CSCs, as already reported in previous
studies by us [18] and others [19]. With respect to the methylation
patterns the two models also behave in a radically different way.
The CSC model shows a patch-like distribution that originates
from single founder CSCs while the clones in the classical model
tend to follow a radial expansion pattern, as can be appreciated
from Figure 1C (Video S3) and 1D (Video S4) in which
epigenetically distinct clones are indicated by different colors.
The CSC model is also characterized by slower tumor growth and
less cell divisions per unit time due to the smaller population of
long-term dividing cells (Figure S1A and S1B). The difference in
population size between the two models can be summarized by the
CSC fraction present in the clone defined as the ratio between the
number of CSCs and the total volume at each point in time. In the
classical model this value is always 1 whereas in the CSC model it
can be variable; in our analysis it quickly stabilizes to ,0.2% for
y=0.1 and G=5, this value is in line with experimental estimates
of CSC fractions (Figure S1C) [2,3].
Next we determined the overall heterogeneity of the two
different tumor growth models by calculating the Shannon index.
Author Summary
Cancer is in essence a genetic disease that leads to
uncontrolled cell proliferation, invasion and metastasis.
The cancer stem cell (CSC) hypothesis states that tumors
are not just a mass of uniform malignant cells but they are
hierarchically organized, like normal tissues. At the top of
such a hierarchy are cancer stem cells that fuel tumor
growth in the long run, whereas the majority of other cells
are able to divide only a few times. The experiments that
support the CSC hypothesis are often criticized as being
difficult to interpret. A novel approach to test the CSC
paradigm is to integrate mathematical modeling with DNA
variation data that carry the phylogenetic history of cells.
We have developed a model that simulates the occurrence
of such changes under both the CSC hypothesis and the
classical, purely stochastic scenario. We found that
although a CSC-driven tumor has a smaller number of
tumorigenic cells, it triggers more malignant properties
such as invasive growth, heterogeneity and evolutionary
escape from peaks in the fitness landscape. These
properties, that are unique to the CSC model, are
enhanced even further when a treatment is applied to
the tumor.
Modeling Hierarchically Organized Tumors
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The Shannon index [20] is the most frequently applied measure of
heterogeneity in biodiversity studies used to describe a population
consisting of individuals of genotypically different subpopulations.
This measure is based on information theory and possesses
properties that account for species richness within an environment.
In our case we measure the Shannon index of the cancer cell
population and normalize it to the interval [0,1] where 0 indicates
a homogeneous population with only one clone and 1 a fully
heterogeneous population where all the subclones are equally
present (see Materials and Methods). This measure indicates that
the CSC malignancy develops a much higher epigenetic
heterogeneity both in the total population (Figure 2A) and in the
CSC compartment alone (Figure 2B), compared to the classical
model (n = 16, p = 1027 for 100,000 cells). The CSC model
reaches levels of heterogeneity that are 25% of the maximum
possible heterogeneity. These differences can also be appreciated
when the non-normalized Shannon index is considered (Figure
S2A and S2B). The high standard deviations reported in these
plots also suggest that a high level of stochasticity is exhibited by
growth driven by a small number of CSCs. As we will discuss
further, this feature of CSC driven tumor growth has critical
consequences in the evolutionary dynamics of malignancies when
non-neutral mutations are considered.
The enhanced heterogeneity is especially striking since within
the CSC model the effective population size, i.e. the number of
cells contributing to tumor growth in the long run (the CSCs), is
about 500 times smaller than in the non-hierarchical model.
Moreover we assumed the mutation rate for an individual cell is
equal in both models. We confirmed that these results are not
dependent on the particular set of parameters we applied, as we
observe a similar outcome for different values of the number, G, of
transient amplifying stages (Figure S3A). Moreover, different
apoptosis rates for both the classical and the CSC model, or
varying the mutation rate does not change our overall conclusions
(Figure S3B, S3C and S4). Interestingly, the parameter G has a
non-trivial effect on the hierarchical model: high values of G
correspond to long-living TACs that add proliferative potential to
the clone. On the other hand small values of G may also increase
the CSC ratio due to the small number of cells produced by TACs.
In addition, a higher apoptosis rate induces higher heterogeneity
by stimulating more cell divisions in both models; however
difference was significant only for the CSC model (p = 0.01).
We propose that the increased heterogeneity in the CSC model
is due to the fundamental intrinsic property of hierarchical growth
models that are driven by long-lived CSCs that must undergo a
large number of cell divisions to keep fueling the growing cancer
population and thereby acquire more (epi)genetic hits. On top of
this mechanism, the probability that a specific clone takes over a
subregion of the tumor of size N purely by drift, i.e. in a scenario
of neutral mutations, is ,1/N whereas for the CSC model is
,1/(Ny) due to the limited proliferative potential of TACs.
Hence, under equal environmental conditions and mutation rate,
a CSC-driven tumor can achieve higher epigenetic heterogeneity
solely due to its hierarchical organization. This is despite the
smaller effective population size of a CSC-driven malignancy. This
feature, as well as the distribution of methylation patterns
(Figure 1C and 1D) could potentially be used as a signature of a
CSC-driven malignancy in established human tumors.
Non-neutral mutations over a fitness landscape
So far we have shown how hierarchical organization of
malignant cells has a major effect on the heterogeneity and spatial
distribution of neutral methylation patterns. To study the
difference between the two models in term of evolutionary
dynamics, we now consider non-neutral epigenetic mutations that
confer changes in terms of cell fitness.
Because of the complex interaction between genetic loci,
mutations can be mutually deleterious yet confer a fitness
advantage when they occur together [21]. Other mutations
appear to be mutually exclusive, suggesting that co-occurrence
of these genetic alterations confers a fitness disadvantage [22]. The
fitness landscape is defined as a map between the space of possible
mutations and the fitness advantage conferred by the phenotypes
to which they relate. The fitness landscape involved in initiation
and progression of malignancies is believed to be a complex curve,
with valleys, peaks and local minima and maxima [21,23]. To
represent the effects of different fitness landscapes on a growing
cancer we assume that as the population of cancer cells introduces
new mutations, the fitness of individuals moves across a certain
fitness landscape function f(x). We approximate the evolutionary
process by assuming that changes in fitness can occur only by
mutations that cause local movements within the fitness function,
such as x R x+1 or x R x21.
We summarize the complex mechanisms behind the accumu-
lation of epigenetic mutations into a non-neutral mutation rate
parameter mf = 0.1 per cell division that induces changes in the cell
phenotype x, that in turn corresponds to a division rate f(x). In this
scenario clones with different replication times compete with each
other for space. A further selective force is represented in our
model by apoptosis, occurring at a constant rate that affects
relatively slowly dividing clones more dramatically. To illustrate
this, we assume a space of 50 phenotypes with x M [224,+25] with
solid boundary conditions (no mutation can occur beyond the
borders) on which we define different fitness landscapes, both
Table 1. Parameters of the cellular Potts model.
Parameter Symbol Value Reference/Justification
Cell cycle duration c 20 h [52]
Methylation rate (per CpG per cell division) m 261025 [15]
Cell adhesion coefficient J 9 [53]
Cell stiffness l 3 Derived from [53]
Maximum number of cell divisions per TAC G 5 (3, 7 in Figure S3C) Vary G and y to vary CSC fractions [2,18]
Apoptosis rate (fraction per 24 h) a 0.01 (0, 0.04 in Figure S3A-B) Rate lower than CSC growth rate
Apoptosis rate (fitness) af 0.02 Rate lower than CSC growth rate
Non-neutral mutation rate mf 0.1 [28]
doi:10.1371/journal.pcbi.1001132.t001
Modeling Hierarchically Organized Tumors
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linear and non-linear as well as symmetric and asymmetric, and
we compare the behavior of the two models of growth under such
fitness conditions. We start all the simulations with a single cell
possessing the phenotype x0 = 0 that can randomly move right or
left along the x-axis. We simulate growth of the neoplasm until a
volume of 100,000 cells is reached (see Table 1 for the other
parameters used).
In the simplest case we define a linear fitness curve fL(x) = x+8
(with fL(x) = 1 for negative values of x) in which the replication
rate increases proportionally to x (Figure 3A, n = 8). As expected,
in both models the bulk of the population tends towards clones
expressing higher fitness (high values of x). Importantly, it is
apparent how the CSC model shows the property of spreading
much faster across the fitness landscape compared to the classical
model. The CSC model mainly explores higher fitness regions,
yet also phenotypes with relatively low fitness values are
abundantly present. This is in line with our previous finding that
the CSC model stimulates heterogeneity and we argue that this
effect has to do with the lower selective pressure present in the
CSC model that allows clones with no direct survival benefit to
coexist in the neoplasm and contribute to tumor growth.
Furthermore, this peculiar property has consequences in the
evolutionary process because it allows populations to visit, and
eventually cross, regions of the landscape with lower fitness values
that nevertheless may lead to beneficial phenotypes in the long
run (fitness valleys).
Figure 1. Morphology of the classical model and the CSC model. Tumor morphology appears spherical in the classical model (A) whereas
tumor borders in the CSC model are irregular (B). Red: CSCs, yellow: TACs, blue: DCCs (zoom box, black: cell borders). The distribution of the neutral
methylation patterns is radial in the classical model (C) versus patch-like in the CSC one (D).
doi:10.1371/journal.pcbi.1001132.g001
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To evaluate the response of the models to more complex fitness
variations we defined a sinusoidal function fS(x) = 32x sin(x/2) (with
fS(x) = 1 for negative values). This function is characterized by fitness
valleys that lead to peaks with faster replicating phenotypes in the
long run. An example of a fitness valley is the cooperation of the
oncogenes Myc and RAS in mice [24]. Whereas these oncogenes
promote tumorigenesis when both are mutated, the mutation of
only one of them has an anti-cancer effect due to the induction of
apoptosis in Myc-mutated cells and senescence in RAS-mutated
ones. From these types of study it is concluded that the crossing of
fitness valleys is therefore an important mechanism that occurs
during tumorigenesis and tumor progression. To simulate this
property we apply a sinusoidal fitness function (Figure 3B, n= 8).
Here we observe how the evolutionary properties of the classical
model prevent clones from overcoming local minima due to the
stringent action of phenotypical selection. The cancer cell
population can evolve only within the restricted central part of
the fitness landscape that represents the local optimum. Strikingly,
because of the weaker effect of selection and the more important
role of drift, the CSC population can expand to a broader part of the
fitness curve and acquire more aggressive phenotypes in the long
term. A very similar pattern is illustrated in Figure 3C where the
fitness peaks are more numerous due to a slightly different fitness
function f ’S(x) = x sin(x)+2. Here again the classical model adapts to
the local fitness landscape whereas the CSCmodel can escape it and
reach further evolutionary peaks. This dynamical evolutionary
mechanism, driven not only by selection but also by drift, is even
more evident when we analyze different growth stages of the
experiments presented in Figure 3C (Figure S5). This highlights how
the distribution of the clones dynamically probes the fitness landscape
and ultimately reaches higher fitness points.
To perturb the symmetrical effects of randommutations we define
a third function with asymmetric properties to further analyze the
response of the models. The fitness landscape fC(x) = x cos(x/2)+2
specifies a similar function to the previous one but it has
asymmetrical properties with respect to the y-axis (Figure 3D). Once
more the results suggest a conservative behavior of the classical
model that quickly adapts to the local maximum and, in contrast, a
highly dynamical behavior of the CSCmodel that instead overcomes
fitness valleys during a fast exploration of the fitness landscape.
To eliminate the bias introduced by an expanding population
we investigate the stationary distribution of the phenotypes in a
non-expanding malignancy. For this we run a set of simulations
with the sinusoidal fitness function fS(x) in which we start with a
volume of 25,000 cells and maintain constant population size by
randomly killing cells to maintain the original volume, until a total
of 1.2 million cell divisions is reached in both models of tumor
growth. This approach shows that the findings we described for
expanding malignancies are confirmed for a stationary scenario
with constant population size and an equally large number of cell
divisions in both models (Figure S6).
Clearly, in both models the clone distribution does not simply
scatter through dispersion but is driven by the fitness function that
offers local peaks near the starting point with relatively easy access
and other higher peaks that are preceded by low fitness values.
While the classical model remains trapped within those initial local
maxima, the CSC model is free to move ahead to higher fitness
peaks, showing its ability to overcome fitness valleys. In all our
results, the classical model emerges as a model of growth primarily
driven by selection for the (non-optimal) fittest clones that
outcompete the large number of tumorigenic cells in their
neighborhood. In this type of scenario overcoming local maxima
and exploring large portions of the fitness landscape becomes
impossible. Within high selective pressure conditions, any cell that
acquires even a slightly lower fitness (approaching a fitness valley)
due to a disadvantageous mutation would be immediately out-
competed by the surrounding cells with higher fitness. The higher
robustness of the CSC model, induced by its lower selective
pressure that allows for the proliferation of several clones with no
selective advantage, increases the adaptability of the cancer
population that also becomes more evolvable. The lower selective
pressure allows cells to approach a fitness valley and bear
temporarily disadvantageous mutations such as RAS with wildtype
Myc [24] to survive in a sort of spatial evolutionary niche. Such
cells could then carry on accumulating aberrations, such as Myc in
this example, and become more malignant in the long run. This
Figure 2. The CSC model enhances methylation pattern heterogeneity. Despite its much smaller effective population size, the CSC model
(red) shows consistently higher heterogeneity (A) with respect to the classical (blue) model of malignancies (p = 1027 at 100,000 cells, a = 0.01).
Importantly this measure is even enhanced when considering the CSC compartment only (B) (p = 1027 at 100,000 cells). Error bars represent SD with
n= 16.
doi:10.1371/journal.pcbi.1001132.g002
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direct but counterintuitive relationship between robustness and
evolvability has recently been discussed by Draghi and colleagues
[25]. In a CSC-driven malignancy such robustness is not assumed
a priori, depending on a specific fitness landscape, but emerges
naturally from the hierarchical organization itself. These results
show how a hierarchically organized populations of cancer cells,
despite having the disadvantage of a smaller effective cell
population size, can escape stringent selective forces represented
by cancer therapies that target fast dividing cells. Such treatment
modalities would be highly effective in a selection-driven classical
model of growth. This therapy-escaping mechanism present in
hierarchical malignancies may lead to a more invasive and
therapy-resistant cancer through faster accumulation of diverse
clones and evolutionary escape of local fitness peaks.
Evolutionary dynamics associated with treatment
To investigate the influence of therapy in the different cancer
scenarios we simulate the application of treatment when the
tumor volume reaches 30,000 cells. At that point in time, all
proliferating cells (see Material and Methods) are killed,
independently of their differentiation status. The remaining cells
are left to repopulate the tumor and form the relapse. We analyze
the status of the tumor just before therapy and after the relapsed
neoplasm has again reached the volume of 30,000 cells. As an
example we consider the sinusoidal fitness function fS(x) with the
same conditions as employed before. Whereas the classical model
displays no evident difference between the two time points (the
neoplasm has just regrown similarly to its primary counterpart),
in the CSC model the therapy has radically altered the
distribution of the phenotypes, pushing larger populations of
cells to occupy higher fitness peaks (Figure 4A and 4B). The
phenotypical heterogeneity of the clones does not significantly
change in the CSC model (p = 0.46) while it decreases slightly in
the classical model (p = 0.02) (Figure S7A). However, the average
fitness does increase considerably in the CSC model (p = 0.0023)
and yet only minimally in the classical model (p= 0.04) (Figure S7B).
Figure 3. The CSC model escapes local fitness peaks and achieves better fitness in the long run. Within a linear fitness function fL(x)
= x+8 (A) the CSC model tends to spread towards low fitness regions too, rather than just selecting for the fastest replicating clone. In the case of a
symmetrical fitness function with peaks and valleys fS(x) = 32x sin(x/2) and f’S(x) = x sin(x)+2 (B,C) the CSC model shows evolutionary superiority and
the ability to escape local peaks and reach higher fitness in the long run. Even more clearly, the same evolutionary differences are present under an
asymmetrical fitness function fC(x) = x cos(x/2)+2 (D). Error bars represent SD with n= 8.
doi:10.1371/journal.pcbi.1001132.g003
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According to this analysis the CSC model not only relapses more
aggressively, but it also changes the phenotypical composition of
its clones, resulting in a relapsed neoplasm that is radically
different from the originally treated one. In the classical model
most of the cells stay within the local fitness peak seeking the
highest local fitness point. Cells that eventually survive therapy
are still trapped within the same peaks and the tumor that
develops after relapse is very similar to the primary one. Said
differently, the CSC model also allows less fit clones to survive in
the lower parts of the fitness landscape. In this way cells are not
only prone to cross fitness valleys, but in case of treatment, they
can survive due to their slow cycling phenotype. Hence, the
relapsed tumor benefits from the further expansion of the clone
pool towards even more aggressive phenotypes. This mechanism
results not only in the increase of aggressiveness of the neoplasm
at time of relapse, but also in a very different clonal composition
of the tumor. The behavior of the CSC model therefore suggests
that the fundamental organization of malignant clones may
directly influence the therapeutic effect of treatment and the
acquisition of resistance in cancers.
Discussion
Modeling tumor growth using cellular automata, partial
differential equations and hybrid models has revealed some of
the important underlying dynamics of the growth of malignancies
[26]. Since the models proposed by Dormann and Deutsch [27] it
has been possible to simulate the formation of a three-layered
structure in tumors, made by proliferating, quiescent and necrotic
layers. Successively, more advanced hybrid models have shown
how the invasion patterns in malignancies could arise from the
interaction with the microenvironment [28]. A similar hybrid
approach, incorporating the CSC concept, has illustrated how a
small population of stem-like cells in cancer can drive tumor
invasion with a mechanism that the authors define as self-
metastasis [19]. Using a cellular automata approach we have
previously shown that tissue invasion and intra-tumor heteroge-
neity could arise from the internal organization of the clone itself,
from its interaction with the microenvironment or from a complex
mixture of both [18,29].
Recently, cellular automata based on Potts models [30] have
been developed to simulate the dynamics of populations of cells
[31]. Models derived from this paradigm have been successfully
employed in cancer research to predict the conditions for cancer
cell survival and the diffusion dynamics of growth factors [32]. In
this work we use a similar approach to model the cellular growth
of malignancies but for the first time to our knowledge, we
integrate the cellular Potts modeling approach with the hierarchi-
cal organization of cancer cell populations and with the
occurrence of neutral and non-neutral mutations to study the
evolutionary dynamics of malignancies. We put special emphasis
on the process of cancer evolution [33] since this covers the most
fundamental questions in cancer research such as the progression
of tumors to invasive and metastatic neoplasms.
In evolutionary terms, cancer cells compete for resources such
as oxygen, glucose and space, both with other cancer clones as well
as with normal cells surrounding the malignancy. The limit of
available resources, such as the space to proliferate, induces a
selective pressure on the expanding neoplasm. Each cancer cell
competes for proliferation within those limits, a mechanism
summarized in our model with the space constraint and random
apoptosis. In this context, malignant cells with higher fitness can
outcompete their neighbors in terms of proliferation and so lead to
clone expansion. Hence, a fully clonogenic tumor, i.e. a tumor in
which all cells posses the capacity to proliferate indefinitely,
appears to be the best organization to develop further malignant
traits and clonal heterogeneity, as observed in tumors in vivo
[34,35,36].
However, our investigations suggest that under the same
environmental conditions and mutation rate, the evolutionary
dynamics of neutral epigenetic changes in tumors lead to the
counter-intuitive emergence of intra-tumor heterogeneity in
hierarchically organized malignancies. This process seems to be
intrinsic to the organization present in the malignant clone itself
and need not depend upon external microenvironmental factors.
Certainly, the tumor microenvironment has been shown to play an
important role in cancer, in particular in modulating stem cell
features of cancer cells [37,38]. Although we do not take this into
consideration in the present study, previous results suggest that a
Figure 4. The CSC model stimulates malignant features in relapsing tumors after therapy. Whereas the relapsing tumors in a classical
model are highly similar to the primary ones, displaying an unaltered average fitness (A, p = 0.04), the CSC model not only shows a different clonal
distribution, but also the average fitness is considerably increased (B, p = 0.0023). Error bars represent SD with n= 12.
doi:10.1371/journal.pcbi.1001132.g004
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model where the stemness is intrinsic to the cell and a model where
instead it is completely determined by the microenvironment yield
similar results regarding the clonal evolution of the malignancy
[29]. In our future studies we plan to incorporate this aspect of
tumor biology in more detail; in fact our cellular Potts model
approach is a natural framework to study this type of interaction.
The CSC compartment may be fixed or display plasticity driven
by the microenvironment; in both cases a tumor organization that
stimulates heterogeneity through genetic drift [18,33] and
promotes the emergence of clones without a direct survival benefit
may allow a more malignant evolution of a cancer cell population
[39]. Furthermore, we have shown how in the CSC model cancer
cells are free to explore the landscape of possible genetic
alterations, overcome fitness valleys (local minima) and escape
from local fitness peaks (Figure 3, S5 and S6), as also observed in
the evolution of small populations [40] and in the adaptability of
robust phenotypes [25]. We believe that such growth could give
rise to radically different evolutionary dynamics, unlike the
scenario where only the fittest individuals overcome the compet-
itors. Instead, we propose that populations of cancer cells can raise
their survival chances not only through their relative fitness, but
also by increasing genetic drift through a mechanism of
segregation. In this way, individuals could achieve survival because
of the lowered selective pressure and increased genetic drift, rather
than through stringent competition. This last mechanism can
occur by means of migration but also through hierarchical
organization of clones that consequently would occur in
segregation of individuals through asymmetric division of stem-
like cells.
In a highly competitive environment with scarce resources such
as in a tumor microenvironment, being fitter (e.g. proliferating
faster) may be too expensive and/or disadvantageous in the long
run since it diminishes the heterogeneity of the total population, as
we demonstrated in this study. Alternatively, a clone could evolve
through an easier yet riskier path, such as due to lower selective
pressure and increased genetic drift induced by any mechanism of
segregation. This suggests an intimate relationship between
evolution and organization of a malignant clone: the hierarchical
structure of growth could be advantageous in evolutionary terms
with respect to a flat structure, despite its apparently limited
proliferative potential. Generally, this process could occur in other
types of evolving populations. These findings directly support the
need for using spatial models in the study of evolutionary dynamics
of tumor growth.
On top of these mechanisms, a hierarchically organized cancer
population has the capacity to regenerate after treatment,
presenting a relapsed neoplasm that displays more aggressive
traits and a substantially different clonal composition compared to
its primary counterpart. This is especially intriguing as relapsed
tumors are often considerably different from the original
malignancy in many features including aggressiveness and clonal
composition. This fact is usually attributed to the selection of
clones that are relatively resistant to particular drugs during
treatment [41,42,43]. However, our findings indicate that a CSC-
driven malignancy has intrinsic features that explain such behavior
independently of clonal resistance.
In conclusion this work presents a theoretical study of the
emerging properties of CSC-driven tumor growth. It clearly points
out interesting and counterintuitive features of hierarchically
organized models of growth. To corroborate our findings by
means of experimentation, a possible approach would be to
employ extensive methylation sequencing [15,17] of in vitro or in
vivo tumors known to retain a CSC organization [44]. Our
predictions could help to establish if rare CSCs are effectively
present in tumors, as advocated by the CSC hypothesis. More
importantly, our results refer directly to an in vivo context that can
be accessed in terms of methylation analysis, a scenario that
transplantation and in vitro experiments are unable to reproduce
convincingly. Finally, our study elucidates evolutionary mecha-
nisms that have critical implications for therapy resistance of
tumors such as the increased heterogeneity, the escape from local
fitness peaks and the capacity to present a completely altered
malignancy after treatment.
Materials and Methods
The tumor growth model
To simulate a malignancy and the mutations occurring in it we
developed a mathematical model of tumor growth based on a
Cellular Potts Model (CPM) [30]. A CPM is a Monte Carlo
computational modeling technique developed in the field of
statistical mechanics. Our model allows us to simulate several
important processes occurring in the growth of a tumor such as
cell proliferation, cell membrane deformation and cell-to-cell
adhesion. A CPM represents the system, in our case the tumour, as
a 2-dimensional lattice V with N6N sites. Each cell has a unique
identifier s that defines the cell volume Vs and shape within the
lattice [45]. To each cell identifier is also assigned a cell type t(s),
in our case for instance a cancer stem cell or a differentiated
cancer cell. In a CPM we can simulate cell proliferation and
adhesion by representing these processes as transitions from
energetically unfavorable states to energetically favorable ones. In
this manner, for example, a compressed cell would seek to
maintain its volume by creating a counterforce. The total energy
of the system can be described by a simple Hamiltonian:
H~EvzEa ð1Þ
with Ev the cell elastic energy and Ea the cell membrane contact
energy. These variables correspond to the cost of a certain cell
state in terms of energy.
Volume elastic energy
Ev~
X
s
lt(s) Vs{Vtrj j ð2Þ
Under no mechanical stress, the volume of a cell Vs is equal to its
target volume Vtr, thus elastic energy Ev = 0. Under compression or
stretch, the cell elastic energy increases as described by (2), where
the cell elastic coefficient lt(s) depends only on the cell type t(s).
Cell adhesion energy
Ea~
X
(i,j)(i0 , j0 )neighbours
J t(si, j),t(si0 ,j 0 )
 
ð1{bsi, jsi0 ,j 0 Þ ð3Þ
The energy cost J(t1,t2) is assigned to each contact point of the
cell membranes, and depends on the cell type. The term b in (3)
avoids counting points belonging to the same cell. This method
simulates cell membrane adhesion in a simple and elegant manner.
At each time step dt we evolve the system by randomly drawing
a certain number of random local changes in a Monte Carlo
fashion, those changes can be accepted or rejected as illustrated by
the Metropolis algorithm below [46]:
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1. Compute system energy H
2. Pick a random lattice site (i, j)
3. Set the content s of (i, j) to that of its neighbor (i’, j’), chosen at
random
4. Calculate the energy difference DH=Hnew – H
5. If DH,0 accept new state because the total energy is lower
6. If DH$0 accept new state with probability p~exp({ DHkT )
7. If cell is growing, increase target volume Vtr = Vtr+dV
8. If Vs.2Vtr divide cell (Vs tries to grow to size Vtr since it is a
lower energy state)
9. Go to 1
This technique allows us to simulate efficiently and in an elegant
way several crucial processes occurring in cancer. Our model
proved to be very flexible and computationally fast and therefore
suitable to perform statistical inference of biological parameters, as
in the case of the colon crypt [47]. Here we propose an extension
of such a model to simulate large cancer cell populations within a
malignancy. The model simulates the expansion of malignant cells
that originate from a single initial cancer cell that can proliferate
by invading the surrounding tissue (not simulated) while
accumulating DNA mutations according to any mutation scheme
we need. Because cancers are accompanied by massive cell death
we introduce in our model an apoptosis rate a that corresponds to
the fraction of cells randomly selected for death every 24 h. This
parameter allows us to investigate the influence of apoptosis in the
dynamics of cancer epigenetic alterations in cancer.
On top of this tumor growth model, we implemented the CSC
hierarchy by assuming two possible cell types in the system: cancer
stem cells (CSC) and more differentiated cancer cells (DCC). At
every division a CSC has probability d to self-renew and therefore
generate a new CSC, and probability 1-y to spin off a TAC.
TACs can undergo a maximum of G divisions before becoming
fully differentiated and irreversibly stopping division. By changing
the parameter y we can modify the size of the CSC compartment,
spanning tumors with a very small population of CSCs (y,1) to
the classical model of malignancies where all cells in the tumor are
tumorigenic and have stem-like features (y=1). In this model no
active cell migration is considered, however cells may diffuse due
to low cell-to-cell adhesion and the distribution of mechanical
forces within the tumor.
To implement cell fitness advantage, in relationship to a certain
fitness landscape, we assign to each cell a specific phenotype in the
range [225,25] with the first cell starting with phenotype 0. To
each phenotype x corresponds a fitness value f(x), representing the
growth rate of the cells possessing that phenotype. In the model
this corresponds to the increase of target volume dV implemented
in the step 7 illustrated above. In this way cells with a faster
growing phenotype will reach the target volume faster and will
consequently divide more often.
Although we have also developed a 3-dimensional version of the
model, in this paper we make use of a 2-dimensional implemen-
tation of it. This represents a tumor as a sheet of cells and permits
us to study the global evolutionary dynamics of a considerably
larger cancer cell population by enhancing the computational
feasibility. We believe that to investigate the dynamics we discuss,
a two-dimensional model is a good and efficient solution, as for
most tumor growth models [18,32,48,49,50,51]. Moreover, agent-
based models of tumor growth like the one we describe have
proved to yield equivalent results in both two and three
dimensions [18,28]. In general, simulation times on a 2.5 GHz
Xeon CPU were of ,8 h for the classical model experiments and
,20 h for the CSC model simulations assuming V=200062000
with 16 points per cell.
Measure of heterogeneity
To measure the level of clonal diversity in the tumor population
we make use of the Shannon index of biodiversity [20] normalized
to the interval [0,1]. The Shannon index is a measure of
biodiversity of species within an ecosystem, in our case different
methylation patterns within the tumor. A high value of the
Shannon index indicates that all the species present in the
ecosystem (the different methylation patterns in the malignancy)
are present in equal numbers, a small Shannon index instead
represents a scenario where one or few patterns are present in
large numbers and virtually dominate the other patterns.
The Shannon index H is calculated as in equation (4),
J~{
XS
i~1
piln(pi) ð4Þ
where pi is the relative abundance of species i (a specific
methylation pattern). For any given number of species S there is
a maximum possible Shannon index of Jmax = log S that reflects
the highest possible biodiversity in the system where all species are
present in equal number. In our analysis we consider the
normalized Shannon index J’ =J/Jmax at any given point in
time. According to this measure a value of 0 corresponds to the
presence of a single dominant clone whereas a value of 1
represents a heterogeneous neoplasm where all the subclones are
present in equal numbers.
Supporting Information
Figure S1 Timescales and population size. The classical model
(blue) displays faster growth rate (A) and larger amount of cell
divisions per time (B) due to a fully tumorigenic population
whereas the tumorigenic fraction in the CSC model (red) is limited
to ,0.2% of the total (C). Error bars represent SD with n= 16, see
Table 1 for details on parameters used.
Found at: doi:10.1371/journal.pcbi.1001132.s001 (0.63 MB EPS)
Figure S2 Heterogeneity of the cancer stem cell population.
Increased heterogeneity for the CSC model is reported also with
the standard Shannon index for the total population (A) as well as
for the CSC compartment only (B). Error bars represent SD with
n = 16.
Found at: doi:10.1371/journal.pcbi.1001132.s002 (0.52 MB EPS)
Figure S3 Heterogeneity for different values of G and apoptosis
rate. In both the classical (A) and the CSC model (B) the apoptosis
rate modestly stimulates methylation pattern heterogeneity by
inducing a larger number of cell divisions although in the CSC
model this effect is significant (p = 0.009) whereas in the classical
model it is not (p = 0.41). Different sizes of the TAC compartment
have a non-trivial effect on heterogeneity (C) yet for the examined
values only G=7 significantly alters the results (p = 0.0002). Error
bars represent SD with n = 16.
Found at: doi:10.1371/journal.pcbi.1001132.s003 (0.64 MB EPS)
Figure S4 Robustness for variations of the mutation rate. The
results are significantly robust with respect to changes in mutation
rates although for lower mutation rates the differences are non
significant due to the necessity to simulate much larger populations
under very rare mutation events. Error bars represent SD with
n = 8.
Found at: doi:10.1371/journal.pcbi.1001132.s004 (0.46 MB EPS)
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Figure S5 Evolution of non-neutral mutations at different
growth stages. The evolutionary behavior of the two models is
illustrated for growth points using the sinusoidal function fS’(x).
Here the mechanism of fitness landscape probing using genetic
drift that characterizes the CSC model is evident from the change
of distribution of the clones during growth. The volumes
considered are 1k (A), 5k (B), 10K (C), 20k (D), 50k (E) and
100k (F). Error bars represent SD with n = 8.
Found at: doi:10.1371/journal.pcbi.1001132.s005 (1.13 MB EPS)
Figure S6 The evolutionary dynamics of the CSC model are
confirmed under constant population size and equal number of
divisions. The same ability of the CSC model to overcome local
maxima and achieve better fit in the long run while maintaining a
pool of low-fitness clones is confirmed also when the population is
maintained at constant size (25,000 cells) and compared to the
classical model after 1.2M cell divisions. Error bars represent SD
with n = 8.
Found at: doi:10.1371/journal.pcbi.1001132.s006 (0.49 MB EPS)
Figure S7 Heterogeneity and average fitness of the two models.
After treatment in both models the overall heterogeneity of the
clones remains similar (A, CSC p= 0.46, classical p = 0.02). Yet
the average fitness of the CSC model is dramatically increased in
the regrown tumors (B, CSC p=0.0023, classical p = 0.04). Error
bars represent SD with n = 12.
Found at: doi:10.1371/journal.pcbi.1001132.s007 (0.45 MB EPS)
Video S1 Simulated growth of a classical (flat) tumor.
Found at: doi:10.1371/journal.pcbi.1001132.s008 (1.08 MB AVI)
Video S2 Simlated growth of a hierarchically organized tumor.
Found at: doi:10.1371/journal.pcbi.1001132.s009 (3.36 MB AVI)
Video S3 Methylation patterns in a classical (flat) tumor.
Found at: doi:10.1371/journal.pcbi.1001132.s010 (0.21 MB AVI)
Video S4 Methylation patterns in a hierarchically organized
tumor.
Found at: doi:10.1371/journal.pcbi.1001132.s011 (1.91 MB AVI)
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